mkt_predictor...DDSS ($2.18) is a forward-looking play for February. I wanted to get an early jump on it. They have been through the challenges last August of needing to update their facility for production of the drug that the FDA had concerns about. No questions were raised regarding the efficacy or safety of Trazadone.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.